Predictive Value of Tumor‑Infiltrating Lymphocytes and Ki‑67 for Pathological Response to Total Neoadjuvant Therapy in Rectal Cancer

Faculty Medicine Year: 2024
Type of Publication: ZU Hosted Pages: 8
Authors:
Journal: Journal of Gastrointestinal Cancer Humana Press Volume: Volume 55, pages 869–876, (2024)
Keywords : Predictive Value of Tumor‑Infiltrating Lymphocytes and Ki‑67 for Pathological    
Abstract:
Abstract: Purpose: Patients with locally advanced rectal cancer (LARC) who underwent total neoadjuvant therapy (TNT) showed an increase in the percentage of complete pathological response (pCR). The purpose of this study was to determine the correlation between Ki-67, tumor-infiltrating lymphocytes (TIL), and TNT in LARC patients. Method: In total, one hundred fifty-nine patients with LARC were included in this prospective study. The international working group was used to categorize the TIL into three groups based on the percentage and density of staining: group 0 (0–10%), group 1 (11–59%), and group 2 (≥60%). Ki-67 expression was classified as low (≤50%) or high (>50%). Result: Most patients had tumor grade III (74.2%) and T2–T3 (78.6%). Lymph node involvement (48.7%) and tumor size≥3 cm were detected in approximately half of the patients. Forty-four percent of patients had a high Ki-67 index; 15.7% of patients belonged to group 1, and 21.4% belonged to group 2. pCR was detected in 18.2% of the patients. TIL and Ki-67 levels were significantly correlated with pCR (p=0.001 and 0.003 for multivariate analysis and 0.001 and 0.03 for univariate analysis, respectively). Conclusion: There was a statistically significant correlation between Ki-67, TIL, and pCR following TNT protocol, which may help maximize the therapeutic outcome
   
     
 
       

Author Related Publications

  • Adel Salah Bakry, "Clinical and Prognostic Significance of PD-L1, Beclin 1 and Fascin 1 Immunohistochemical Expression in Colorectal Carcinoma", The journal is published by Dr Hemant Jain for JCDR Research and Publications (P) Limited. JCDR Research and Publications (P) Limited has primary obj, 2023 More
  • Adel Salah Bakry, "The Prognostic Significance of ACLR and HALP Scores in Hepatocellular Carcinoma Patients Treated with Sorafenib", Yara Naser Mohamed Email: yaraarlo95@gmail.com, 2024 More
  • Adel Salah Bakry, "Clinicopathological significance of protein disulphide isomerase A3 and phosphorylated signal transducer and activator of transcription 3 in cervical carcinoma", Journal published under the patronage of Stowarzyszenia na Rzecz Walki z Rakiem „Geny Życia” (Poznan) and Fundacji Onkologii Doświadczalnej i Kliniczn, 2024 More
  • Adel Salah Bakry, "Combination of Cisplatin and Temozolomide versus Carboplatin and Etoposide in the Treatment of Recurrent High Grade Glioma Patients", Zagazig University, Faculty of Medicine, 2024 More
  • Adel Salah Bakry, "Assessment of Chemotherapy Induced Ovarian Failure Using Serum Anti￾Mullerian Hormone in Premenopausal Breast Cancer Patients", Zagazig University, Faculty of Medicine, 2024 More

Department Related Publications

  • Rasha Mohamed Mostafa Hagag, "Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib", Zagazig University Medical Journal, 2022 More
  • Rasha Mohamed Mostafa Hagag, "Diagnosis of Sepsis among Adult Patients with AML Using Scd14", Ain Shams University, Faculty of Medicine, Pan Arab League of Continuous Medical Education, 2021 More
  • Rasha Mohamed Mostafa Hagag, "Prognostic Impact of microRNAs (miR-155, miR-10a, let-7a) on the Outcome of Adult Patients with Acute Myeloid Leukemia.", Zagazig University, Faculty of Medicine, 2021 More
  • Shereen Mostafa Saleh Elshorbagy, "Prognostic Roles of ZNF703 and SMAD4 Expression in Patients with Papillary Thyroid Cancer and Association with Nodal Metastasis", pubmed, 2022 More
  • Shereen Mostafa Saleh Elshorbagy, "RNA-binding proteins RBM-HuR, RBM3 and PODXL expression in urothelial carcinoma of the urinary bladder. Prognostic and clinical implications", PMID: 35079236, 2022 More
Tweet